-
1
-
-
34848837386
-
Taking dendritic cells into medicine
-
Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449:419-426.
-
(2007)
Nature
, vol.449
, pp. 419-426
-
-
Steinman, R.M.1
Banchereau, J.2
-
2
-
-
22144439081
-
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer immunology, immunotherapy
-
Knutson K.L., Disis M.L. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer immunology, immunotherapy. Cancer Immunol. Immunother. 2005, 54:721-728.
-
(2005)
Cancer Immunol. Immunother.
, vol.54
, pp. 721-728
-
-
Knutson, K.L.1
Disis, M.L.2
-
3
-
-
0032546352
-
Dendritic cells and the control of immunity
-
Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
-
(1998)
Nature
, vol.392
, pp. 245-252
-
-
Banchereau, J.1
Steinman, R.M.2
-
4
-
-
0037083571
-
Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand
-
Lu G., Janjic B.M., Janjic J., Whiteside T.L., Storkus W.J., Vujanovic N.L. Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand. J. Immunol. 2002, 168:1831-1839.
-
(2002)
J. Immunol.
, vol.168
, pp. 1831-1839
-
-
Lu, G.1
Janjic, B.M.2
Janjic, J.3
Whiteside, T.L.4
Storkus, W.J.5
Vujanovic, N.L.6
-
5
-
-
34250324345
-
Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells
-
Stary G., Bangert C., Tauber M., Strohal R., Kopp T., Stingl G. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J. Exp. Med. 2007, 204:1441-1451.
-
(2007)
J. Exp. Med.
, vol.204
, pp. 1441-1451
-
-
Stary, G.1
Bangert, C.2
Tauber, M.3
Strohal, R.4
Kopp, T.5
Stingl, G.6
-
6
-
-
0034893581
-
Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism
-
Steitz J., Bruck J., Knop J., Tuting T. Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism. Gene Ther. 2001, 8:1255-1263.
-
(2001)
Gene Ther.
, vol.8
, pp. 1255-1263
-
-
Steitz, J.1
Bruck, J.2
Knop, J.3
Tuting, T.4
-
7
-
-
60849084473
-
Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells
-
Lopez M.N., Pereda C., Segal G., Munoz L., Aguilera R., Gonzalez F.E., Escobar A., Ginesta A., Reyes D., Gonzalez R., Mendoza-Naranjo A., Larrondo M., Compan A., Ferrada C., Salazar-Onfray F. Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells. J. Clin. Oncol. 2009, 27:945-952.
-
(2009)
J. Clin. Oncol.
, vol.27
, pp. 945-952
-
-
Lopez, M.N.1
Pereda, C.2
Segal, G.3
Munoz, L.4
Aguilera, R.5
Gonzalez, F.E.6
Escobar, A.7
Ginesta, A.8
Reyes, D.9
Gonzalez, R.10
Mendoza-Naranjo, A.11
Larrondo, M.12
Compan, A.13
Ferrada, C.14
Salazar-Onfray, F.15
-
8
-
-
73349123487
-
Dendritic cells from bench to bedside and back
-
Adema G.J. Dendritic cells from bench to bedside and back. Immunol. Lett. 2009, 122:128-130.
-
(2009)
Immunol. Lett.
, vol.122
, pp. 128-130
-
-
Adema, G.J.1
-
9
-
-
0029753767
-
Retroviral transduction of human dendritic cells with a tumor-associated antigen gene
-
Reeves M.E., Royal R.E., Lam J.S., Rosenberg S.A., Hwu P. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res. 1996, 56:5672-5677.
-
(1996)
Cancer Res.
, vol.56
, pp. 5672-5677
-
-
Reeves, M.E.1
Royal, R.E.2
Lam, J.S.3
Rosenberg, S.A.4
Hwu, P.5
-
10
-
-
0037379315
-
Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine
-
Kao J.Y., Gong Y., Chen C.M., Zheng Q.D., Chen J.J. Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine. J. Immunol. 2003, 170:3806-3811.
-
(2003)
J. Immunol.
, vol.170
, pp. 3806-3811
-
-
Kao, J.Y.1
Gong, Y.2
Chen, C.M.3
Zheng, Q.D.4
Chen, J.J.5
-
11
-
-
0037086079
-
Strategies for antigen loading of dendritic cells to enhance the antitumor immune response
-
Strome S.E., Voss S., Wilcox R., Wakefield T.L., Tamada K., Flies D., Chapoval A., Lu J., Kasperbauer J.L., Padley D., Vile R., Gastineau D., Wettstein P., Chen L. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res. 2002, 62:1884-1889.
-
(2002)
Cancer Res.
, vol.62
, pp. 1884-1889
-
-
Strome, S.E.1
Voss, S.2
Wilcox, R.3
Wakefield, T.L.4
Tamada, K.5
Flies, D.6
Chapoval, A.7
Lu, J.8
Kasperbauer, J.L.9
Padley, D.10
Vile, R.11
Gastineau, D.12
Wettstein, P.13
Chen, L.14
-
12
-
-
34250753161
-
Cell death modalities: classification and pathophysiological implications
-
Galluzzi L., Maiuri M.C., Vitale I., Zischka H., Castedo M., Zitvogel L., Kroemer G. Cell death modalities: classification and pathophysiological implications. Cell Death Differ. 2007, 14:1237-1243.
-
(2007)
Cell Death Differ.
, vol.14
, pp. 1237-1243
-
-
Galluzzi, L.1
Maiuri, M.C.2
Vitale, I.3
Zischka, H.4
Castedo, M.5
Zitvogel, L.6
Kroemer, G.7
-
13
-
-
84876416160
-
How does ionizing irradiation contribute to the induction of anti-tumor immunity?
-
Rubner Y., Wunderlich R., Ruhle P.F., Kulzer L., Werthmoller N., Frey B., Weiss E.M., Keilholz L., Fietkau R., Gaipl U.S. How does ionizing irradiation contribute to the induction of anti-tumor immunity?. Front Oncol. 2012, 2:75.
-
(2012)
Front Oncol.
, vol.2
, pp. 75
-
-
Rubner, Y.1
Wunderlich, R.2
Ruhle, P.F.3
Kulzer, L.4
Werthmoller, N.5
Frey, B.6
Weiss, E.M.7
Keilholz, L.8
Fietkau, R.9
Gaipl, U.S.10
-
14
-
-
12144288198
-
Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity
-
Kim K.W., Kim S.H., Shin J.G., Kim G.S., Son Y.O., Park S.W., Kwon B.H., Kim D.W., Lee C.H., Sol M.Y., Jeong M.H., Chung B.S., Kang C.D. Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity. Int. J. Cancer 2004, 109:685-690.
-
(2004)
Int. J. Cancer
, vol.109
, pp. 685-690
-
-
Kim, K.W.1
Kim, S.H.2
Shin, J.G.3
Kim, G.S.4
Son, Y.O.5
Park, S.W.6
Kwon, B.H.7
Kim, D.W.8
Lee, C.H.9
Sol, M.Y.10
Jeong, M.H.11
Chung, B.S.12
Kang, C.D.13
-
15
-
-
42649099297
-
Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy
-
Teitz-Tennenbaum S., Li Q., Okuyama R., Davis M.A., Sun R., Whitfield J., Knibbs R.N., Stoolman L.M., Chang A.E. Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy. J. Immunother. 2008, 31:345-358.
-
(2008)
J. Immunother.
, vol.31
, pp. 345-358
-
-
Teitz-Tennenbaum, S.1
Li, Q.2
Okuyama, R.3
Davis, M.A.4
Sun, R.5
Whitfield, J.6
Knibbs, R.N.7
Stoolman, L.M.8
Chang, A.E.9
-
16
-
-
5844264920
-
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
-
Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R., Greenfield E.A., Bourque K., Boussiotis V.A., Carter L.L., Carreno B.M., Malenkovich N., Nishimura H., Okazaki T., Honjo T., Sharpe A.H., Freeman G.J. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001, 2:261-268.
-
(2001)
Nat. Immunol.
, vol.2
, pp. 261-268
-
-
Latchman, Y.1
Wood, C.R.2
Chernova, T.3
Chaudhary, D.4
Borde, M.5
Chernova, I.6
Iwai, Y.7
Long, A.J.8
Brown, J.A.9
Nunes, R.10
Greenfield, E.A.11
Bourque, K.12
Boussiotis, V.A.13
Carter, L.L.14
Carreno, B.M.15
Malenkovich, N.16
Nishimura, H.17
Okazaki, T.18
Honjo, T.19
Sharpe, A.H.20
Freeman, G.J.21
more..
-
17
-
-
34249977835
-
The JAM Test and its daughter P-JAM: simple tests of DNA fragmentation to measure cell death and stasis
-
Usharauli D., Perez-Diez A., Matzinger P. The JAM Test and its daughter P-JAM: simple tests of DNA fragmentation to measure cell death and stasis. Nat. Protoc. 2006, 1:672-682.
-
(2006)
Nat. Protoc.
, vol.1
, pp. 672-682
-
-
Usharauli, D.1
Perez-Diez, A.2
Matzinger, P.3
-
18
-
-
0037092973
-
Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin
-
Spisek R., Chevallier P., Morineau N., Milpied N., Avet-Loiseau H., Harousseau J.L., Meflah K., Gregoire M. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin. Cancer Res. 2002, 62:2861-2868.
-
(2002)
Cancer Res.
, vol.62
, pp. 2861-2868
-
-
Spisek, R.1
Chevallier, P.2
Morineau, N.3
Milpied, N.4
Avet-Loiseau, H.5
Harousseau, J.L.6
Meflah, K.7
Gregoire, M.8
-
19
-
-
0348135024
-
Dendritic-cell control of pathogen-driven T-cell polarization
-
Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 2003, 3:984-993.
-
(2003)
Nat. Rev. Immunol.
, vol.3
, pp. 984-993
-
-
Kapsenberg, M.L.1
-
20
-
-
0141449950
-
Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant
-
Johansson-Lindbom B., Svensson M., Wurbel M.A., Malissen B., Marquez G., Agace W. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J. Exp. Med. 2003, 198:963-969.
-
(2003)
J. Exp. Med.
, vol.198
, pp. 963-969
-
-
Johansson-Lindbom, B.1
Svensson, M.2
Wurbel, M.A.3
Malissen, B.4
Marquez, G.5
Agace, W.6
-
21
-
-
79953295544
-
The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity
-
Burnette B.C., Liang H., Lee Y., Chlewicki L., Khodarev N.N., Weichselbaum R.R., Fu Y.X., Auh S.L. The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. Cancer Res. 2011, 71:2488-2496.
-
(2011)
Cancer Res.
, vol.71
, pp. 2488-2496
-
-
Burnette, B.C.1
Liang, H.2
Lee, Y.3
Chlewicki, L.4
Khodarev, N.N.5
Weichselbaum, R.R.6
Fu, Y.X.7
Auh, S.L.8
-
22
-
-
3042569675
-
External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing
-
Chakraborty M., Abrams S.I., Coleman C.N., Camphausen K., Schlom J., Hodge J.W. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Cancer Res. 2004, 64:4328-4337.
-
(2004)
Cancer Res.
, vol.64
, pp. 4328-4337
-
-
Chakraborty, M.1
Abrams, S.I.2
Coleman, C.N.3
Camphausen, K.4
Schlom, J.5
Hodge, J.W.6
-
23
-
-
34548576109
-
Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis
-
Obeid M., Panaretakis T., Joza N., Tufi R., Tesniere A., van Endert P., Zitvogel L., Kroemer G. Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis. Cell Death Differ. 2007, 14:1848-1850.
-
(2007)
Cell Death Differ.
, vol.14
, pp. 1848-1850
-
-
Obeid, M.1
Panaretakis, T.2
Joza, N.3
Tufi, R.4
Tesniere, A.5
van Endert, P.6
Zitvogel, L.7
Kroemer, G.8
-
24
-
-
2942700201
-
High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization
-
Messmer D., Yang H., Telusma G., Knoll F., Li J., Messmer B., Tracey K.J., Chiorazzi N. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 2004, 173:307-313.
-
(2004)
J. Immunol.
, vol.173
, pp. 307-313
-
-
Messmer, D.1
Yang, H.2
Telusma, G.3
Knoll, F.4
Li, J.5
Messmer, B.6
Tracey, K.J.7
Chiorazzi, N.8
-
25
-
-
48749085127
-
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
-
Gilliet M., Cao W., Liu Y.J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 2008, 8:594-606.
-
(2008)
Nat. Rev. Immunol.
, vol.8
, pp. 594-606
-
-
Gilliet, M.1
Cao, W.2
Liu, Y.J.3
-
26
-
-
84857542033
-
Sub-lethal irradiation of human colorectal tumor cells imparts enhanced and sustained susceptibility to multiple death receptor signaling pathways
-
Ifeadi V., Garnett-Benson C. Sub-lethal irradiation of human colorectal tumor cells imparts enhanced and sustained susceptibility to multiple death receptor signaling pathways. PloS One 2012, 7:e31762.
-
(2012)
PloS One
, vol.7
-
-
Ifeadi, V.1
Garnett-Benson, C.2
-
27
-
-
20144362968
-
Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells
-
Shi J., Ikeda K., Fujii N., Kondo E., Shinagawa K., Ishimaru F., Kaneda K., Tanimoto M., Li X., Pu Q. Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells. Cancer Sci. 2005, 96:127-133.
-
(2005)
Cancer Sci.
, vol.96
, pp. 127-133
-
-
Shi, J.1
Ikeda, K.2
Fujii, N.3
Kondo, E.4
Shinagawa, K.5
Ishimaru, F.6
Kaneda, K.7
Tanimoto, M.8
Li, X.9
Pu, Q.10
-
28
-
-
0035810046
-
Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells
-
Shao R.G., Cao C.X., Nieves-Neira W., Dimanche-Boitrel M.T., Solary E., Pommier Y. Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells. Oncogene 2001, 20:1852-1859.
-
(2001)
Oncogene
, vol.20
, pp. 1852-1859
-
-
Shao, R.G.1
Cao, C.X.2
Nieves-Neira, W.3
Dimanche-Boitrel, M.T.4
Solary, E.5
Pommier, Y.6
-
29
-
-
0037468930
-
Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells
-
Lacour S., Micheau O., Hammann A., Drouineaud V., Tschopp J., Solary E., Dimanche-Boitrel M.T. Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells. Oncogene 2003, 22:1807-1816.
-
(2003)
Oncogene
, vol.22
, pp. 1807-1816
-
-
Lacour, S.1
Micheau, O.2
Hammann, A.3
Drouineaud, V.4
Tschopp, J.5
Solary, E.6
Dimanche-Boitrel, M.T.7
-
30
-
-
0037968644
-
Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen
-
Gilliet M., Kleinhans M., Lantelme E., Schadendorf D., Burg G., Nestle F.O. Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen. Blood 2003, 102:36-42.
-
(2003)
Blood
, vol.102
, pp. 36-42
-
-
Gilliet, M.1
Kleinhans, M.2
Lantelme, E.3
Schadendorf, D.4
Burg, G.5
Nestle, F.O.6
-
31
-
-
0345304868
-
Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model
-
Kuga H., Morisaki T., Nakamura K., Onishi H., Noshiro H., Uchiyama A., Tanaka M., Katano M. Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model. Oncogene 2003, 22:7838-7847.
-
(2003)
Oncogene
, vol.22
, pp. 7838-7847
-
-
Kuga, H.1
Morisaki, T.2
Nakamura, K.3
Onishi, H.4
Noshiro, H.5
Uchiyama, A.6
Tanaka, M.7
Katano, M.8
-
32
-
-
0036157853
-
HLA class I antigen abnormalities and immune escape by malignant cells
-
Seliger B., Cabrera T., Garrido F., Ferrone S. HLA class I antigen abnormalities and immune escape by malignant cells. Semin. Cancer Biol. 2002, 12:3-13.
-
(2002)
Semin. Cancer Biol.
, vol.12
, pp. 3-13
-
-
Seliger, B.1
Cabrera, T.2
Garrido, F.3
Ferrone, S.4
-
33
-
-
0037302729
-
IFN-gamma sensitization of prostate cancer cells to Fas-mediated death: a gene therapy approach
-
Selleck W.A., Canfield S.E., Hassen W.A., Meseck M., Kuzmin A.I., Eisensmith R.C., Chen S.H., Hall S.J. IFN-gamma sensitization of prostate cancer cells to Fas-mediated death: a gene therapy approach. Mol. Ther. 2003, 7:185-192.
-
(2003)
Mol. Ther.
, vol.7
, pp. 185-192
-
-
Selleck, W.A.1
Canfield, S.E.2
Hassen, W.A.3
Meseck, M.4
Kuzmin, A.I.5
Eisensmith, R.C.6
Chen, S.H.7
Hall, S.J.8
-
34
-
-
34848855542
-
New approaches for monitoring CTL activity in clinical trials
-
Malyguine A., Strobl S., Zaritskaya L., Baseler M., Shafer-Weaver K. New approaches for monitoring CTL activity in clinical trials. Adv. Exp. Med. Biol. 2007, 601:273-284.
-
(2007)
Adv. Exp. Med. Biol.
, vol.601
, pp. 273-284
-
-
Malyguine, A.1
Strobl, S.2
Zaritskaya, L.3
Baseler, M.4
Shafer-Weaver, K.5
-
35
-
-
10244279184
-
Mechanisms and functional significance of tumour-induced dendritic-cell defects
-
Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 2004, 4:941-952.
-
(2004)
Nat. Rev. Immunol.
, vol.4
, pp. 941-952
-
-
Gabrilovich, D.1
|